期刊文献+

平阳霉素诱导化疗在T_2舌鳞癌治疗中的应用价值 被引量:2

Role of Induction Chemotherapy with Bleomycin A5 in Treating Stage T_2 Tongue Squamous Cell Carcinoma
下载PDF
导出
摘要 背景与目的:诱导化疗在舌鳞癌治疗中具有重要作用,本研究目的在于探讨单药平阳霉素诱导化疗在T2舌鳞癌治疗中的应用价值。方法:回顾性分析单纯手术及单药平阳霉素诱导化疗加手术分别治疗36例舌鳞癌T2病变患者后,对其生存及复发情况的影响。结果:单纯手术组及诱导化疗加手术组的5年生存率分别为81.46%和57.14%,差异有显著性(P=0.0229);区域/局部复发率分别为22.2%和33.3%,中位复发时间分别为20和24个月。对Ⅱ、Ⅲ期及Ⅳ期患者,两种治疗措施的5年生存率无显著差异(P=0.0949;P=0.0739)。在Ⅲ及Ⅳ期病变中,单纯手术组和诱导化疗加手术组的区域/局部复发率分别为12.5%和35.7%,中位复发时间分别为12和12.8个月。结论:单药平阳霉素诱导化疗对舌鳞癌T2病变的治疗价值不大。不管是早T2病变还是晚T2病变,它对患者的5年生存率没有明显影响,对局部控制率的影响仍有待进一步观察。 Background & Objective:Induction chemotherapy play an important role in treatment of the patients with tongue squamous cell carcinoma.This study was designed to evaluate the role of induction chemotherapy with single agent bleomycin A5 in treating stage T2 tongue squamous cell cancinoma. Methods:The authors retrospectively analyzed the influence of surgery and induction chemotherapy with single agent bleomycin A5 plus surgery on survival rate and locoregional control among 72 patients with tongue squamous cell carcinoma. Results:The 5 year survival rates were 81.46% and 57.14% respectively for the group of surgery alone and the group of induction chemotherapy plus surgery,the difference between the two groups were significant (P=0.0229). The rates of locoregional recurrence were 22.2%,33.3% and the medial time of recurrence was 20,24 months respectively in the two groups. For the patients in stageⅡ and stageⅢ plus stageⅣ,there was no difference between the two groups for the 5 year survival rate (P=0.0949;P=0.0739). For the patients in stage Ⅲ plus stageⅣ,the rates of locoregional recurrence were 12.5%,35.7% and the medial time of recurrence was 12,12.8 months,respectively,in the two groups. Conclusions:It has no significant role in treatment of the patients with stage T2 tongue squamous cell carcinoma for single agent bleomycin A5. Induction chemotherapy using single agent bleomycin A5 did not improve the 5 year survival rate for early or late primary lesions. The impact on the control rate of locoregional recurrence would be studied further for single agent bleomycin A5.
出处 《癌症》 SCIE CAS CSCD 北大核心 2002年第12期1372-1375,共4页 Chinese Journal of Cancer
关键词 治疗 舌鳞癌 诱导化疗 预后 Tongue squamous cell carcinoma Induction chemotherapy Prognosis
  • 相关文献

参考文献7

  • 1曾宗渊..实用头颈肿瘤学[M],1996.
  • 2争光霉素协作组.平阳霉素治疗恶性肿瘤的临床疗效评价[J].中华肿瘤杂志,1979,1:172-174. 被引量:8
  • 3宋明,陈福进,曾宗渊,伍国号,魏茂文,郭朱明,张诠,杨安奎.诱导化疗在中晚期舌癌治疗中的价值[J].癌症,2002,21(1):68-70. 被引量:10
  • 4Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma:three meta-analyses of updated individual data [J]. Lancet, 2000, 355:949-955. 被引量:1
  • 5Lin JC, Jan JS, Hsu CY, et al. High rate of clinical complete response to weekly outpatient induction chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin [J]. Cancer, 1999, 85(7):1430-1438. 被引量:1
  • 6Basu S, Khanra M, Dash B, et al.The role of induction and adjuvant chemotherapy regimens consisting of different combinations of drugs in the treatment of advanced oral cancer [J]. Med Oncol, 1999, 16(3):199-203. 被引量:1
  • 7郭朱明,曾宗渊,陈福进,张诠,许光谱,杨安奎.临床Ⅳ期舌鳞癌新辅助化疗研究[J].耳鼻咽喉(头颈外科),1998,5(6):362-364. 被引量:10

二级参考文献6

  • 1曾宗渊,赖国强,陈福进,魏茂文,伍国号,许光普,朱小波,陈直华,郭朱明,谢汝华,闵华庆.舌癌662例远期疗效观察[J].癌症,1989,8(5):368-371. 被引量:17
  • 2吴跃煌,唐平章,祁永发.舌鳞癌综合治疗疗效分析[J].耳鼻咽喉(头颈外科),1996,3(5):303-307. 被引量:5
  • 3Brockstein BE.Reduction of distant metastases in head and neck cancer with concomitant chemotherapy [J].J Clin Oncol,2000,18(18): 3320-3331. 被引量:1
  • 4Urba SG,Wolf GT,Bradford CR,et al.Neoadjuvant therapy for organ preservantion in head and neck cancer [J].Laryngoscope,2000,110(12): 2074-2080. 被引量:1
  • 5Harari H.Why Has Induction Chemotherapy for Advanced Head and Neck Cancer Become a United States Community Standard of Practice [J].J Clin Oncol,1997,15(5): 2050-2055. 被引量:1
  • 6郭朱明,曾宗渊,陈福进,张诠,许光谱,杨安奎.临床Ⅳ期舌鳞癌新辅助化疗研究[J].耳鼻咽喉(头颈外科),1998,5(6):362-364. 被引量:10

共引文献23

同被引文献23

  • 1梁利荣,周歧,阮方超,杨卫江.口腔鳞癌新辅助化疗的回顾性研究[J].口腔医学研究,2004,20(3):302-304. 被引量:3
  • 2孙传政,陈福进,李晓江,曾宗渊,隋军,邓莅霏,陈艳峰.中期舌体鳞状细胞癌的预后及诱导化疗在治疗中的价值[J].中华耳鼻咽喉头颈外科杂志,2007,42(4):273-276. 被引量:2
  • 3Shah JP, William M. Bueeal mueosa, alveolus, retromolar trigone, floor of mouth, hard palate, and tongue tumor//Thawley SE, Panje WR, Batsakis JG. Comprehensive management of head and neck tumors. 2nd. Philadelphia: Sannders, 1999:686-719. 被引量:1
  • 4Magrin J, Kowalski LP, Saboia M, et al. Major glossectomy : end results of 106 cases. Eur J Cancer B Oral Oncol,1996,32B:407-412. 被引量:1
  • 5Ruhl CM, Gleich LL, Gluckman JL Survival, function, and quality of life after total glossectomy. Laryngoscope, 1997, 107:1316-1321. 被引量:1
  • 6Bova R, Cheung I, Coman W. Total glossectomy: is it justified?ANZ J Surg,2004, 74: 134-138. 被引量:1
  • 7Kirita T, Shimooka H, Yamanaka Y, et al . Prognostic value of response to preoperative chemoradiotherapy and residual tumor grades in tongue carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2001,91:293-300. 被引量:1
  • 8Licitra L, Grandi C, Guzzo M, et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol, 2003,21:327-333. 被引量:1
  • 9Faivre S, Marti A, Rixe O, et al. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of thehead and neck. Head Neck,2005,27:311-319. 被引量:1
  • 10Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:three meta-analyses of updated individual data. Lancet, 2000,355:949-955. 被引量:1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部